Cellectis S.A. (NASDAQ: CLLS) has announced that it will be unveiling its third quarter financial results on Monday 4th November 2024. This announcement is set to occur after market close, allowing investors and analysts to gain valuable insights into the company's performance during the quarter.
The financial experts on Wall Street are predicting that the business will likely report an estimated $0.21 loss per share for the third quarter. Additionally, it is anticipated that the company will reveal a $5.4 million revenue during the quarter.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share loss of $0.36. Moreover, the company achieved a remarkable total revenue of $1.64 million during that quarter.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $31.31 million. Moreover, they anticipate the company to disclose loss of $0.79 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-0.27 | -80.0% | 9.50 M | +374.7% |
| Q1 2024 | $-0.14 | +74.5% | 6.50 M | +82.6% |
| Q4 2023 | $-0.57 | 0% | 1.99 M | -88.5% |
| Q3 2023 | $-0.36 | +37.9% | 1.64 M | -14.4% |
| Q2 2023 | $-0.15 | +58.3% | 2.00 M | -27.6% |
| *Growth on year-over-year basis | ||||
CLLS will host a conference call with investment community on 5th November 2024 at 08:00 AM eastern time to discuss the financial results.
Throughout Friday's trading, Cellectis S.A. (CLLS) shares fluctuated between $1.78 and $1.81, with a trading volume of 87.20 thousand shares. The stock ended the regular trading session at $1.80, demonstrating a gain of 1.12 percent.
